PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Western European Percutaneous Coronary Intervention Devices Market Offers Opportunities for Entrants with Advanced Products Reveals Frost & Sullivan - The highly competitive western European percutaneous coronary intervention (PCI) devices market offers growth potential for entrants providing technologically advanced products
Western European Percutaneous Coronary Intervention Devices Market Offers Opportunities for Entrants with Advanced Products Reveals Frost & Sullivan

 

NewswireToday - /newswire/ - London, United Kingdom, 2010/01/19 - The highly competitive western European percutaneous coronary intervention (PCI) devices market offers growth potential for entrants providing technologically advanced products.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The technology involved in the market for PCI devices is highly complex. In addition, new product launches occur frequently, requiring expert explanation. Such trends are creating solid growth opportunities.

New analysis from Frost & Sullivan (medicaldevices.frost.com), Western European Markets for Percutaneous Coronary Intervention (PCI) Devices, finds that the market earned revenues of $1.63 billion in 2008 and estimates this to reach $2.64 billion in 2015. Coronary stents, coronary catheters, coronary guidewires, angioplasty balloons, balloon inflators and embolic protection devices are the market sectors covered in the research.

"There have been rapid technological advancements, especially in the stent and catheter market sectors," notes Frost & Sullivan Research Analyst Sreevidhya Praveen. "Scientists and entrepreneurs are developing novel technologies that offer significant improvements over current technologies. This, together with strong intellectual property and a comprehensive clinical development plan, is set to attract venture capitalists."

Reinforcing market prospects is the increasing government focus on cardiovascular disease (CVD) as a public health issue. CVD is the leading cause of premature death in Europe. An ageing baby boomer population and sedentary lifestyles is set to increase the number of CVD patients.

At the same time, developments in imaging technology have enhanced the accuracy and safety of cardiac surgery and implantation. This has led to an increase in the number of attempted interventional procedures.

However, well-entrenched competitors threaten the viability of smaller companies.

"A major concern among new participants is the huge R&D expense that a device company has to incur in order to develop devices, conduct clinical trials, gain approval and market the devices," explains Praveen. "The spate of high-profile mergers and acquisitions in the market has further weakened the potential for the rapid growth of smaller companies."

To successfully penetrate the market, companies should forge long-term contracts and relationships with distributors and acute and alternate care facilities.

"In order to compete with the larger participants and expand market share, smaller manufacturers need to gain the preference of distributors, hospitals and alternate care facilities," advises Praveen.

Western European Markets for Percutaneous Coronary Intervention (PCI) Devices is part of the Medical Devices Growth Partnership Services programme, which also includes research in the following markets: Medical Devices Industry: Trends During the Recession, Western European Markets for Wound Closure and, Medical Device Company Profiles. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

If you are interested in more information about this study, please send an email to Katja Feick, Corporate Communications, at katja.feick[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.

Western European Markets for Percutaneous Coronary Intervention (PCI) Devices (M457)

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Western European Percutaneous Coronary Intervention Devices Market Offers Opportunities for Entrants with Advanced Products Reveals Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Katja Feick 
+49 (0) 69 7703343 katja.feick[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps
Frost & Sullivan Highlights iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  K A C, Images and U, LLC





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)